The first effective systemic therapy in clinical practice in GIST and DFSP was imatinib - tyrosine kinase inhibitor acting on KIT and PDGFR alpha/beta.
Due to previous reports that claimed the presence of CD117 in DFSP, we designed a model of antigen retrieval under extreme conditions with two cases of DFSO from our archives.